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ABSTRACT
Objective: The overall aim of this thesis was to collect longitudinal information about 
hearing thresholds and complications due to otitis media with effusion (OME) in 
children with cleft palate. Since OME is highly prevalent in children with cleft palate, 
many authors have hypothesized that the hearing loss associated to OME contributes 
to the delayed development of early speech and language often seen in these  children. 
There is a lack of knowledge whether the OME-associated hearing loss is more severe 
in children with cleft palate compared to children with OME but without cleft. 
Methods: Audiological and otological data were reviewed retrospectively in a 
group of children with unilateral cleft lip and palate (UCLP) from 4-10 years of 
age. Results of hearing tests and the number of ventilation tube (VT) treatments 
were analyzed (study I). In the prospective longitudinal group comparison study 
audiological and otological data were collected in one group of children with cleft 
palate, and another group of children with OME but without cleft palate. The 
children were followed from the neonatal auditory brainstem response assessment 
(ABR) at 1-4 months of age to 36 months of age. At seven different test occasions, 
age-appropriate hearing tests were performed (study II).
Results: In the group of children with UCLP, the proportion of children with  hearing 
loss in the speech frequencies decreased with age. However, when examining the 
higher frequencies, this improvement was not found. There were no significant cor-
relations between the number of VT treatments and hearing thresholds at 7-10 years 
of age. Four children (12%) presented with complications;  perforation of the ear 
drum, requiring surgery (two children) and acquired cholesteatoma (two children). 
In the prospective longitudinal study, the comparison of the median four frequency 
average at 500, 1000, 2000 and 4000 Hz (4FA), and the median thresholds at 500 and 
4000 Hz, at 12 months of age, demonstrated significantly better levels in the group of 
children with cleft palate, which might be explained by the early VT  treatment at the 
time of the palate repair, often at 6 months of age (p < 0.001). There were no signifi-
cant group-wise differences in the median 4FA or in any discrete frequencies at 24 
and 36 months of age. Both groups improved over time from the neonatal ABR-test 
to the test at 36 months of age, p < 0.05 in CP±L-group; p < 0.001 in group without 
CP±L. When analyzing the thresholds from 12 months to 36 months of age, there 
was a significant improvement in the group without CP±L (p < 0.001), but not in the 
group with CP±L. At 36 months of age the median 4FA was normal in both groups.
Conclusion: Children with cleft palate have a high prevalence of OME, with a 
subsequent risk for long-term hearing loss. The early VT treatment in children 
with cleft palate appears to be favourable for the short-term hearing; however, 
this should be weighed against the risk for complications. Therefore, this group of 
children requires close monitoring with otological examinations and  audiological 
assessments to ensure that the common OME-associated conductive hearing 
impairment is managed appropriately.
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1INTRODUCTION
Children born with cleft palate need health care from a wide range of professions. 
Feeding, speech, dentition and hearing can be affected, and the interventions should 
be supported by a strongly evidence-based knowledge. If hearing impairment caused 
by otitis media is a risk factor for delayed speech and language  development and 
later problem with academic achievement in children with cleft palate, has been 
discussed but not yet clarified. (Eshghi et al., 2019; Schonweiler et al., 1999; 
Shaffer et al., 2017). However, extended knowledge on hearing loss related to 
otitis media with effusion (OME) in children with cleft palate is needed before 
its relationship with speech and language development can be further explored.
21 BACKGROUND
1.1 Epidemiology cleft palate 
Cleft palate with or without cleft lip (CP±L) is one of the most common 
birth anomalies, and the incidence is approximately 1-2 per 1000 births with 
 ethnic and geographic variations (Hagberg et al., 1998; Mastroiacovo et al., 
2011; Mossey et al., 2009; Mossey and Modell, 2012; Tanaka et al., 2013). 
Studies of the prevalence of additional malformations or syndromes exhibit different 
results, but the definition of associated anomalies and syndromes varies (Milerad 
et al., 1997; Mossey and Modell, 2012). Chetpakdeechit (Chetpakdeechit et al., 
2010) found that in a group of 343 Caucasian children with isolated cleft palate 
(ICP), other birth defects existed in 34 % of the children, and the risk was 1,7 
times higher for a total compared to a partial ICP. Moreover, ICP has been shown 
to have a higher prevalence of associated malformations than unilateral cleft lip 
and palate (UCLP) (Pereira et al., 2018).
1.2 Embryology and etiology  
The central development of the face, head and neck occurs during the first 8 weeks 
of embryogenesis, and during this period most developmental abnormalities occur.
The intermaxillary segment, which derives from the first pharyngeal arch gives rise 
to the philtrum of the upper lip and the primary palate. The upper lip formation is 
completed in the sixth or seventh week. The remainder of the palate forms from the 
palatal shelves which appear late in the sixth week. As the palatal shelves prolifer-
ate, they start to fuse, from anterior to posterior. The fusion of the hard palate is 
complete in the tenth week. The soft palate and uvula develop from mesenchymal 
proliferation at the posterior aspect of the hard palate (Coleman and Sykes, 2001).
The etiology of cleft palate is multifactorial and most of the cases are believed 
to be caused by an interaction of various genetic and environmental factors. Risk 
factors as folic acid deficiency during pregnancy has been discussed (Millacura 
et al., 2017). An increased risk for cleft palate is also seen due to medication with 
anticonvulsive drugs such as valproate during pregnancy, and smoking and  alcohol 
consumption during pregnancy. (Centers for Disease Control and Prevention)
31.3 Classification of cleft palate
The primary palate includes the portion of the maxilla anterior to the incisive fora-
men (pre-maxilla), and the secondary palate involves the palatal shelves posterior to 
the incisive foramen. The secondary palate is divided into the hard and soft palate. 
The subjects with cleft palate in the present two studies had either a unilateral 
cleft lip and palate (UCLP), or an isolated cleft palate (ICP). ICP can involve the 
soft palate only or the soft palate combined with different degrees of cleft of the 
hard palate.
A)     B)
 Fig 1. A Isolated cleft palate (ICP), B Unilateral cleft lip and palate (UCLP) Illustration 
by Liisi Raud Westberg
42 OTITIS MEDIA WITH EFFUSION
2.1 Prevalence and etiology of OME
Bluestone and colleagues examined the role of the Eustachian tube (ET) in the 
pathogenesis of otitis media (Bluestone, 1996). Other authors have suggested that 
the dysfunction of the ET is caused by infections in the middle ear. 
Children with cleft palate with or without cleft lip (CP±L) have been displayed to 
have a high prevalence of otitis media with effusion (OME) in a number of studies 
(Y. W. Chen et al., 2012; Flynn et al., 2009; Grant et al., 1988; Klockars and Rautio, 
2012; Kwan et al., 2011; Valtonen et al., 2005; Yang et al., 2012). In children with cleft 
 palate, the dysfunction of the ET is due to abnormalities in the morphology and/or the 
abnormal insertion of the palatal muscles, m. tensor veli palatine and the m. levator 
veli palatine (Matsune et al., 1991). The lateralization of the insertion of the muscles 
causes a lack of anchorage, which does not allow proper opening of the Eustachian 
tube, and inability to equalize the pressure in the middle ear with the following risk for 
retraction of the tympanic membrane and secretion of mucus. Some authors suggest 
that the dysfunction may be related to a dilated tube (Tasaka et al., 1990; Todd, 1983). 
Fig 2. The horizontal position of the Eustachian tube in children. Illustration by Liisi Raud 
Westberg
The etiology of OME in general population is multifactorial and different risk 
factors increase the prevalence rate. Age, exposure to tobacco smoke, respiratory 
infection, lack of breast-feeding in infancy, craniofacial abnormalities, adenoid 
hypertrophy and family history of otitis media has been identified as risk factors 
(Daly et al., 2010; Martines et al., 2011). 
In general pediatric populations the prevalence rate of OME is decreasing with age 
but several authors describe that there are two peaks in prevalence, one before 2 
years of age and a smaller peak at 5 to 7 years of age (C. H. Chen et al., 2003; Sade 
et al., 2003; Tos et al., 1983; Zielhuis et al., 1990) However, in children with cleft 
palate malformations the high prevalence of OME is not improved as much as in 
the general population and the problem may continue throughout childhood until 
5adult age (Alper et al., 2016; Flynn et al., 2013; Flynn et al., 2009;  Handzic-Cuk 
et al., 2001; Sheahan et al., 2003; Smith et al., 1994).
2.2 OME and hearing loss
The hearing loss associated with OME is fluctuating in degree due to the  variable 
amount and viscosity of the fluid in the middle ears at each episode. Hearing  sensitivity 
as a function of OME has been examined in a prospective study of children from 5 to 
36 months of age by Gravel et al. Hearing thresholds were assessed bimonthly and 
an average threshold of the test frequencies for each visit was then averaged across 
all visits in each year. The children who were  classified as bilaterally OME positive 
during year 1, 2 and 3 had significantly poorer  hearing thresholds than children who 
were classified as OME free. Furthermore, the  analysis showed that, as a group, there 
was no long-term effect of OME on the average thresholds of the four-frequency 
range when the middle-ear became OME free (Gravel and Wallace, 2000).  In a 
systematic and descriptive review, the effect of OME on children’s listening abili-
ties were analyzed. In nine studies, the pure tone average thresholds (3PTA at 500, 
1000 and 2000 Hz) were in the range of 18-35 dB, and in these studies the age of 
the children ranged from 2 to 16 years of age. The audiometric configuration was 
typically flat with the most prominent hearing loss in the lower frequencies, 250 and 
500 Hz and at 8000 Hz when this frequency was tested. In this review the authors 
pointed out that both speech-in-quiet and speech-in-noise assessments were found 
to be impaired but there is a need for standardized speech test material to be able to 
evaluate hearing related disabilities (Cai and McPherson, 2017). 
Some studies suggest that the hearing loss in children with cleft palate and OME is more 
pronounced than in children with OME but without cleft  palate.  (Broen et al., 1996; 
Flynn et al., 2009). In a study by Flynn et al., two groups of children, one group with 
UCLP and one group without cleft were followed prospectively, from 1 to 5 years of age. 
The hearing loss in ears with OME in children with cleft palate was significantly more 
pronounced compared to the hearing loss in ears with OME in children without cleft. 
Hearing impairment in the higher frequencies has been demonstrated in  children 
with chronic otitis (Gravel et al., 2006; Hunter et al., 1996; Margolis et al., 2000; 
Ryding et al., 2005) and in children with cleft palate (Flynn et al., 2013; McDermott 
et al., 1986). Mc Dermott and colleagues examined the hearing thresholds and com-
pared the thresholds in children with cleft palate, children with a high incidence of 
middle-ear disease but without any craniofacial anomalies and a control group of 
children with low incidence of middle-ear disease. The high-frequency thresholds, 
8000-20000 Hz were statistically different in the two groups with a high incidence 
of middle-ear disease compared to the control group. Moreover, there was no statis-
tical difference between the group with cleft palate and the group of children with 
a high incidence of middle-ear disease but without any craniofacial anomalies. A 
toxic effect and a lack of oxygen supply has been suggested to be the reason for 
this hearing loss (Kobayashi et al., 1988).
62.3 Tympanic membrane pathology
Many studies have reported about the frequencies of complications and sequelae 
of the tympanic membrane in children with persistent OME (Daly et al., 2003). 
Myringosclerosis and segmental atrophy are very common in ears treated with ventila-
tion tubes, but several studies have not revealed any significant hearing loss due to these 
abnormalities (Johnston et al., 2004; Schilder et al., 1997; Tos and Stangerup, 1989). 
2.4 Treatment with ventilation tubes and risk for 
 following complications 
Treatment with ventilation tubes (VT) are very common in children with CP±L, 
often at the time of the palatal repair. The optimal time for VT insertion and the 
risk for complications as otorrhea, myringosclerosis, retraction, perforation and 
granulation of the tympanic membrane, permanent hearing impairment, and post-
VT insertion cholesteatoma has been discussed in many studies (Imbery et al., 
2017; Karanth and Whittemore, 2018; Klockars and Rautio, 2012; Phua et al., 
2009; Ponduri et al., 2009; Shaffer et al., 2018). In a systematic review by Kuo and 
colleagues, post-VT complications and sequelae are described in seven articles. 
Eardrum perforation occurred in 1.3 to 19% of ears treated with VT during 1 to 
9 years of follow-up. However, the included studies were underpowered cohort 
 studies, and comparison of VT treated children and non-VT treated regarding out-
come of each complication was insufficient because of very-low-strength evidence. 
The author concluded that “studies up to date does not provide sufficient evidence 
on which to base the clinical practice of how to treat OME-related hearing loss in 
children with cleft palate” (Kuo et al., 2014).
Felton et al. (2018) reviewed six studies to examine the effectiveness and compli-
cations of ventilation tube placement before palatal repair. Three of the included 
studies reported 94-97% of infants with cleft palate having OME at 3-6 months of 
age. The authors of this review study concluded that early VT insertion in children 
with CP±L enables normal hearing thresholds in children with CP±L at an early 
age. On the other hand, there was no comparison regarding long-term outcomes 
between children with VT prior to palatal repair versus VT post palatal repair. 
2.5 Impact of OME on speech and language development
The hearing loss associated with otitis media has been proposed to have a nega-
tive impact on early language acquisition. In a prospective cross-sectional study, 
Friel-Patti and Finitzo examined a group of children from 6 to 24 months of age 
regarding the prevalence of OME related to hearing over time. The receptive and 
expressive language skills were evaluated at 12, 18 and 24 months of age, and 
showed that language skills were significantly negative correlated with the number 
of days with effusion and hearing over time (Friel-Patti and Finitzo, 1990; Shriberg 
7et al., 2000). On the other hand, several prospective and randomized clinical trials 
suggest none to minor negative correlation of OME to children´s later speech and 
language development in otherwise healthy children (Paradise et al., 2005; Paradise 
et al., 2003; Zumach et al., 2010). Roberts et al. (2004) performed 11 meta-analysis 
of prospective studies and found no to very small negative associations of OME 
and associated hearing loss to children’s speech and language development. 
Associations between OME associated hearing loss early in life and perceiving 
speech in noise and tasks that require equal binaural hearing at school age were 
examined in a prospective study by Schilder and colleagues. A group of children 
classified as “very persistent OME” group at pre-school age scored significantly 
lower on the speech-in-noise test compared to a group of children with a completely 
negative OME history (Schilder et al., 1994). In a prospective study by Gravel 
and colleagues on children with OME in the first 3 years of life, the assessments 
with conventional audiometry and extended high-frequency audiometry,  distortion 
product otoacoustic emissions, acoustic middle ear muscle reflexes, auditory brain 
stem response (ABR), and higher-order auditory processing measures such as mask-
ing level difference and speech-in-noise were performed at a mean age of 8 years. 
Hearing loss in the extended high frequencies 12.5 and 14 kHz, the contralateral 
acoustic middle ear muscle reflex and the latency of the Wave V ABR response 
were significantly associated with early hearing loss and OME. There was no sig-
nificant relation between distortion product OAE and early  hearing loss and OME, 
 indicating normal middle ear function. Psychoacoustic and speech-in-noise meas-
ures were not associated with early OME and hearing loss (Gravel et al., 2006).
For typically developing children, OME-related hearing loss might not be a sub-
stantial risk factor for later speech and language problems or academic achieve-
ment. However, since most of the studies analyzed the prevalence of OME rather 
than hearing loss, there is a lack of knowledge of the OME-associated hearing loss. 
Consequently, the question whether the hearing loss due to OME in early childhood 
is more severe in children with CP±L compared to children with OME but without 
cleft, and therefore might be a risk factor for later speech and language problems, 
is still to be answered (Hubbard et al., 1985; Eshghi et al., 2019; Schonweiler et 
al., 1999). In particular there is a lack of longitudinal studies on hearing thresh-
olds in young children with CP±L, and in comparison, with children with OME 
but without cleft palate. Such knowledge could guide in choice of intervention as 
well as be a basis for future investigations if OME-related hearing loss is a risk 
factor for speech and language problems.
A summary of four studies conducted to compare hearing thresholds in children 
with and without CP±L, and two studies comparing audiological and early speech 
outcome in children with cleft palate with early VT treatment versus late treatment 
is presented in table 1.
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3 AIM
3.1 General aim
The overall aim of this work was to assemble longitudinal information about 
 hearing thresholds and complications due to OME in children with CP±L. 
3.2 Specific aims 
The study specific aims were in
Study I to:  
•  Define the hearing thresholds of a group of children with UCLP from 4 to 
10 years of age and try to elucidate alterations of the hearing thresholds with 
increasing age.
•  Describe the prevalence of perforation and acquired cholesteatoma and verify 
if VT treatments increase the risk for permanent hearing loss and acquired 
cholesteatoma in this study group. 
Study II to:  
•  Examine if the OME-related hearing loss in early childhood in children with 
CP±L is more severe compared to children with OME but without cleft palate. 
•  Examine if the air conduction thresholds improve with age in children with 
CP±L.
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4 SUBJECTS AND METHODS
4.1 Study groups
4.1.1 Study I
Thirty-seven children (28 boys and 9 girls) born between 1998 and 2006 with 
UCLP without additional malformations and/or syndromes, were enrolled in this 
retrospective medical chart review. The children were participants in a multicentre 
randomized trial on palatal surgery, the Scandcleft project (Semb et al., 2017) in 
which all children were randomized to either a one-stage or a two-stage palatal repair. 
All children in the present paper were treated by the Stockholm Craniofacial Team, 
Karolinska University Hospital. Two children had incomplete audiometric data, 
two children moved from the area which resulted in 33 children (25 boys and 8 
girls) included in the study.
Ethical approval was obtained by the regional ethical committee for the Scandcleft 
project (Dno. 97-372). 
4.1.2  Study II
Two groups of children were followed prospectively and longitudinally from 
9 months of age until 36 months of age. Sixteen children with CP±L and 18  children 
without cleft but with OME were initially enrolled in the study.
All babies with isolated cleft palate born in the Stockholm region between  2012- 2014 
without any associated anomalies, syndromes or other physical impairment and at 
least one native Swedish speaking parent, were invited to participate in this study. 
The recruitment was originally connected to the international project Timing of 
primary surgery of cleft palate (TOPS) (Shaw et al., 2019). However, during the 
second half of the recruitment period, babies born with unilateral cleft lip and 
palate fulfilling the same inclusion criteria, were also invited to participate, in 
order to expand on the number of individuals in the cleft group. All the children 
in the cleft group were treated by the Stockholm Craniofacial Team, Karolinska 
University Hospital.
The infants in the group without cleft palate but with OME were recruited from 
the group of children who failed the neonatal primary hearing screening test and 
had been referred to the Hearing Department at Karolinska University Hospital for 
assessment with an ABR test. The children with ABR thresholds higher than 30 dB 
nHL in at least one ear, were invited to the study. Examination with otoscopy, tympa-
nometry, and ABR was performed to be able to exclude children with sensorineural 
hearing impairment. If the child at the next appointment at 6-9 months of age had 
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OME in at least one ear, they were offered to be enrolled in the study. The  inclusion 
criteria, apart from having a cleft palate, were the same as for the cleft group. 
Three children without cleft palate were later excluded from the study because 
of a permanent unilateral conductive hearing impairment (one child), and a mild 
bilateral sensorineural hearing impairment (two children). The remaining group 
of 31 age-matched children consisted of 16 children with CP±L (10 males), and 
one group of 15 children with OME (9 males) but without CP±L.
All children in the CP±L-group were treated with ventilation tubes bilaterally, 
at the time of the soft palate repair. Twelve children with isolated cleft palate 
received a complete palatal surgery at a mean age of 8.0 months (SD 2.9). The 
four children with unilateral cleft lip and palate had a soft palate repair at a mean 
age of 6.2 months (SD 0.3) and a hard palate closure at 24 months of age. The 
children in the group without CP±L were treated with ventilation tubes in accord-
ance with current evidence for children with OME (Hellström et al., 2011). None 
of the children in the group without cleft palate had ventilation tubes in place 
before 13 months of age.
Ethical approval was obtained by the regional ethical committee for the main 
study: Early development of hearing, speech and language in infants born with 
cleft palate and infants with early ear problems (2012/46-31/2).
4.2 Methods
4.2.1 Medical records (Study I)
The audiograms, the number of hearing tests and the number of VT treatments 
were reviewed from when the children were 4 years until 10 years of age. The 
data were split in two age groups, 4-7 years and >7-10 years of age.
4.2.2 Otoscopy (Study II)
In study II otoscopy was performed at each appointment by one of the authors (BT) 
and was classified as normal, abnormal or with tubes in situ. OME was diagnosed 
if at least one of the following conditions was met: abnormal flat tympanometry 
(type B); abnormal otoscopy with signs of fluid in the middle ear; or abnormal 
tympanometry (type C) and abnormal otoscopy with signs of fluid in the middle ear.
4.2.3 Acoustic impedance (Study II)
The middle ear has an important role to compensate for the impedance mismatch 
between the air in the outer ear canal and the fluid in the inner ear. Assessments 
of the acoustic impedance provide information about the effectiveness of the 
13
mechanical system in the middle ear, and the resistance in the ear against sound 
energy flow, i.e. the efficiency of the sound transmission system in the middle ear. 
Admittance is the reciprocal of impedance and represents the ease of the sound 
energy flow through the system. 
Tympanometry is a technique for measurement of impedance. A probe delivers a 
pure tone in the external ear canal, and a pump connected to the probe alters the 
air pressure in the canal from +200 daPa above (positive pressure) to -400 daPa 
below (negative pressure) atmospheric pressure. With a carrier frequency of 226 
Hz, the stiffness of the tympanic membrane and the ossicular chain, and the air 
pressure in the external canal and the middle ear are the main contributors to the 
impedance. The compliance is the reciprocal of stiffness and can be defined as 
the quotient of a change in volume and the required change in pressure to achieve 
this volume change. At 226 Hz the compliance for an air-filled cavity of 1 ml is 
1 mmho and the compliance can be expressed in equivalent volume in ml or cm³. 
The tympanic membrane is most mobile when the air-pressure in the external ear 
canal reaches the pressure in the middle ear. The normal middle ear pressure in 
children varies between +50 daPa above to – 100 daPa below atmospheric pressure.
Tympanometry was completed with standard equipment, and was classified as 
normal (type A), flat tympanogram (type B), negative pressure (type C) or with 
tubes in situ (Liden, 1969).
4.2.4 Auditory brainstem responses (Study II)
Auditory brainstem responses (ABR) were registered using an Interacoustics Eclipse 
system EP 25. The stimulus consisted of a click (100µs) with a repetition rate of 
39.1 per second. Each recording was individually analyzed by the  audiologist and 
one of the authors (BT). 
ABR thresholds of 30 dB nHL or better were classified as “pass”, thresholds > 30 
dB nHL as “fail” in the group-wise comparison at 1-4 months of age.
4.2.5 Hearing sensitivity (Study I and II)
Pure-tones or warble-tones were used with audiometers according to the interna-
tional standard IEC 60645 and calibrated according to ISO 389.
For study I conditioned play audiometry or tone audiometry under TDH-39P 
(Telephonics) headphones was applied to obtain ear specific thresholds for 500, 
1000, 2000, 4000, 6000 and 8000 Hz. A four frequency pure-tone average (PTA4) 
of 500, 1000, 2000 and 4000 Hz and a high frequency pure-tone average (PTAHF) 
based on 6000 and 8000 Hz were calculated for each ear. For each child, the audio-
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grams with the best thresholds when they were 4-7 and > 7-10 years of age were 
chosen for the analysis. Hearing screening according to clinical protocol at 10, 15 
and 20 dB HL was performed at the age of 4-7 years in seventeen children. The 
screening threshold is not necessarily the absolute threshold, and a comparison 
of mean or median PTA4 does not depict the true situation. Therefore, we chose 
to compare the proportion of children with a normal PTA4 and the children with 
hearing loss at the two different age spans.
The classification of grades of hearing impairment by HEAR (Martini, 2001) are 
demonstrated in table 2. 
Table 2. Classification of hearing impairment by the better ear.
PTA4 in better ear
Normal G%+/
Mild >20-40 dB HL
Moderate >40-70 dB HL
Severe >70 dB HL
The number of children with audiological data in the two age groups 4-7  and > 7-10 
years are presented in table 3. 
Table 3. Number of children with data in the two age groups 4-7 and > 7-10 years. The 
number of children with data at both occasions are presented within parentheses.
Number of children
Group 4-7 y 7-10 y
PTA4 33(30) 30
PTAHF 21(17) 28(17)
At 4-7 years of age, 12 children had missing data at 8000 Hz, and for one of those 
12 children there is also missing data at 6000 Hz bilaterally and for one child 
unilaterally.
In study II the children were followed by assessment of hearing sensitivity at 8 
test occasions from the neonatal ABR test at 1-4 months of age until 3 years of 
age. At the ages of 9, 12, 15, 18, 24, 30 and 36 months of age (±4weeks) data 
about hearing thresholds were collected and at the same appointment the middle 
ear status was examined.
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Behavioral, visually reinforced audiometry (VRA) and/or conditioned play 
audiometry was performed to attain frequency-specific thresholds. An expe-
rienced pediatric audiologist decided which test-method to use, taking into 
consideration the child´s ability to comply with the assessment. In the VRA-
test, a picture appears on a screen when the child responds appropriately to 
a stimulus. In the young infants the tests often had to be done in sound-field, 
but from 30 and 36 months of age most of the children accepted headphones. 
A screening level of 20 dB HL was used when the air-conduction thresholds at 
500, 1000, 2000 and 4000 Hz were assessed and an average of the thresholds at 
those frequencies (4FA) was calculated. The better ear was determined to be the 
ear with the best 4FA, and if the result was the same in both ears, the right ear was 
chosen. For all the analyses in study II the better ear was chosen since ear-specific 
thresholds are not always obtained when the test is performed in a sound-field. 
In order to be able to assess as many subjects as possible longitudinally, three 
ages were chosen, 12, 24 and 36 months of age. Due to missed appointments and 
noncompliance, it was not possible to compile data for this longitudinal analysis 
on all children in the study. Twenty-five children were possible to assess longitu-
dinally; 13 children with CP±L and 12 without cleft. Sixteen of these 25 children 
had complete data at the planned occasions and in 9 children the results from the 
visit directly prior to or after that age, were chosen for the analyses. Group-wise 
comparisons of median ABR thresholds at 1-4 months, median 4FA and frequency-
specific median thresholds at 12, 24 and 36 months of age, were included in this 
longitudinal analysis. 
To be able to compare the proportion of children with hearing loss at each age, 9 
to 36 months, the results of the 4FA in the better ear were classified as “pass” or 
“fail”. It was not possible to determine the 4FA in some children because of non-
compliance and missing data. The children with results at less than four frequen-
cies were included if the average of those frequencies could only yield a “fail” 
result, otherwise the subject was excluded in the comparison at this age. If the 4FA 
was better than the selected cut-off level at 26 dB HL, the result was classified as 
“pass ”. From 24 months of age an additional cut-off level at 21 dB HL was also 
implemented since the ability to cooperate in the assessment situation generally 
increases at this age.   
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4.3 Statistical methods and calculations (Study I and II)
Non-parametric tests were performed when comparing hearing thresholds due to 
their non-normal distribution. 
4.3.1 (Study I)
The McNemar´s test (Statistica, Version 10) was performed to examine the change 
in proportion of children with hearing loss in the two age groups. The relation 
between the number of VT-treatments before 10 years of age and the hearing 
thresholds was examined with the Pearson Correlation test (SPSS, Version 22).
4.3.2 (Study II)
The Mann-Whitney U test was performed to examine the group wise differences in 
ABR, in 4FA and in hearing thresholds at discrete frequencies. Friedman ANOVA 
was used to analyze if the hearing thresholds improved over time. Statistica 13.2 
(Stat Soft®).
The difference in proportion of pass and fail between the CP±L-group and the 
group without cleft palate was analyzed with performance of the Fisher´s exact 
two-tailed test due to the small sample sizes.
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5 RESULTS
5.1 Study I 
5.1.1 Audiometry
According to clinical protocol a screening method was used at the assessments at 
4-7 years of age in seventeen children. The screening level was 10, 15, or 20 dB HL. 
Regarding the PTA4 at 4-7 years of age, two children had a bilateral mild hearing 
impairment, and five children had a unilateral mild hearing impairment. One child 
had a unilateral moderate hearing impairment. At > 7-10 years of age none of the 
children had a bilateral hearing loss in the PTA4, but four children had a mild 
unilateral hearing impairment. Three children had missing data, but no  hearing 
impairment at 4-7 years of age. Thirty children with complete audiometric results 
from 500-4000 Hz at both age intervals were included in the analysis of the dif-
ference in proportion of children with PTA 4 > 20 dB HL (McNemar´s test). A 
significant decrease was found in the proportion of children with PTA 4 > 20 dB 
HL between the two age groups (p < 0.001).
Examining PTAHF at 4-7 years, revealed three children with a mild bilateral, one 
with a moderate bilateral, four with a mild unilateral and one with a moderate 
unilateral hearing impairment. In the older age group > 7-10 years, four  children 
had a bilateral mild hearing impairment and one child a moderate  bilateral  hearing 
impairment. Two children had a mild unilateral and one a moderate unilateral 
 hearing impairment. At this age two children had missing data at 8000 Hz but 
exhibited thresholds at 15 dB HL at 6000 Hz. The statistical analysis of the seven-
teen children with complete audiometric data in the higher frequencies at both age 
intervals, revealed no significant difference in proportion of children with hearing 
impairment in the higher frequencies between the two age groups. 
Table 4. Number and percent of children with unilateral and bilateral hearing loss 
grouped by age and degree of hearing loss. Unilat: unilateral hearing loss, bilat: 
bilateral hearing loss.
Group PTA4 unilat bilat Group PTAHF unilat bilat
4-7 y >20-40 5(15%) 2(6%) 4-7 y >20-40 4(19%) 3(14%)
(n=33) >40-70 1(3%) 0 (n=21) >40-70 1(5%) 1(5%)
7-10 y >20-40 4(13%) 0 7-10 y >20-40 2(7%) 4(14%)
(n=30) >40-70 0 0 (n=28) >40-70 1(4%) 1(4%)
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5.1.2 Prevalence of complications due to VT treatments
Twenty-nine children were treated with ventilation tubes, two as early as before 
six months of age, and most children had their first VT placement between 6 and 
24 months. The number of VT treatments up to 10 years of age varied from eight 
ears with no VT insertions up to 14 ears with seven VT treatments. See publica-
tion I table 4 and fig. 2. 
There was no significant correlation between the number of VT treatments and 
PTA4 or PTAHF for each ear, at > 7-10 years of age (Pearson Correlation test).
Four of the 29 VT treated children exhibited complications. Two children required 
a myringoplasty due to persistent perforation of the ear drum; one child (no. 26) 
had previously undergone four and the other child (no. 15) two VT insertions in 
the ear with the perforation. The hearing thresholds in these two children showed 
D37$G%+/DWERWKDJHVSDQ5HJDUGLQJWKH37$+)DW!\HDUVWKH
child with four VT treatments had a threshold at 15 dB HL bilaterally at 6000 Hz, 
DQGWKHFKLOGZLWKWZR97WUHDWPHQWVKDGD37$+)G%+/ELODWHUDOO\
One child (no. 31) with an implantation cholesteatoma in the left ear at 7 years of 
age, had undergone four VT treatments. Surgery with myringoplasty was performed 
but a retraction pathology required revision surgery three years later. This child 
presented with normal PTA4 at both age spans, but a hearing impairment in the 
higher frequencies bilaterally. The PTAHF at 4-7 years of age was 40 dB HL for 
the left and 45 dB HL for the right ear, and at > 7-10 years 40 dB HL  bilaterally. 
Another child (no. 32) developed retraction pathology and a cholesteatoma in pars 
tensa at 15 years of age. The child had gone through two VT treatments in this 
ear, and at 4-7 years of age had a PTA4 of 21 dB HL but missing data for PTAHF. 
Between > 7-10 years of age, the child presented with normal PTA4 and a mild, 
bilateral hearing impairment in the high frequencies. See table 5. 
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Table 5. Individual data regarding PTA4 and/or PTAHF > 20 dB HL at 4-7 and > 7-10 
years, and the number of VT treatments these children had undergone. (PTA4=Pure 
Tone Average 500, 1000, 2000 and 4000 Hz, PTAHF=Pure Tone Average High 
Frequencies 6000 and 8000 Hz, VT=Ventilation Tube, m.d.= missing data).
Child PTA4 4-7 PTA4 7-10 PTAHF 4-7 PTAHF 7-10 no VT
2 RE 36 9 38 25 6
LE 49 5 48 28 7
4 RE 33 10 43 23 7
LE 10 8 13 23 5
6 RE 19 20 45 53 2
LE 24 21 58 48 2
7 RE 24 24 13 18 2
LE 22 15 15 18 3
17 RE 16 8 m.d. 18 3
LE 23 13  m.d. 15 3
18 RE 39 36 40 55 2
LE 11 0 8 5 3
19 RE 15 8 m.d. 10 5
LE 10 15 m.d. 28 3
20 RE 11 21 m.d. 13 1
LE 11 18 m.d. 8 1
21 RE 14 5 23 13 3
LE 6 1 23 10 3
22 RE 23 6 m.d. 13 1
LE 20 3 m.d. 13 1
27 RE 9 8 20 8 4
LE 20 5 23 13 5
28 RE 14 10 28 13 6
LE 11 14 15 10 6
31 RE 9 8 45 40 3
LE     10 11 40 40 4
32 RE 21 20 m.d. 23 2
LE 15 16 m.d. 23 1
35 RE 10 5 m.d. 18 1
LE 11 10 m.d. 23 1
36 RE 6 3 10 15 2
LE 9 11 23 8 2
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5.2 Study II
5.2.1 ABR
The neonatal median ABR-thresholds was 35 dB nHL (range: 20-45) in the group 
of children with cleft palate and 30 dB nHL (range: 20-45) in the group without. 
Statistical analysis showed no significant difference between the groups (see fig.3).
5.2.2 Audiometry
In the longitudinal group, the comparison of the median 4FA between the two 
groups exhibited a significant difference only at 12 months of age (p < 0.01). At 
this age the children in the CP±L-group had a median 4FA of 22.5 dB HL com-
pared to 31 dB HL in the group without cleft. Furthermore, there was a significant 
difference at the discrete frequencies 500 Hz and 4000 Hz at this age, see table 6. 
Table 6. 12 months median 4 FA and median thresholds with range within parenthesis  
** = p < 0.0.1, Mann-Whitney U test 
CP±L Without CP±L
Median 4FA 22.5 (20-39) 31 (24-41) **
Median 500 Hz 25 (20-45) 35 (30-45) **
Median 1000 Hz 25 (20-45) 30 (25-40) n.s.
Median 2000 Hz 25 (20-35) 30 (20-40) n.s.
Median 4000 Hz 20 (20-30) 30 (20-50) **
Figure 3. Mean neonatal ABR thresholds in dB nHL (CP±L n=16; non- CP±L n=15) and 
4FA at 12, 24 and 36 months of age (CP±L n=13; non- CP±L n=12) per group. **= p < 
0.01, Mann-Whitney U test
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The statistical analyses did not reveal any significant group differences at 24 and 
36 months of age in 4 FA or at any of the discrete frequencies 500, 1000, 2000 
and 4000 Hz. Non-parametric methods were used but for illustrational purposes 
the mean values are presented in the figures 3 and 4a-4c.
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Figure 4 a-c Mean thresholds at 500, 1000, 2000 and 4000 Hz per group at 12, 24 and 36 
months of age (n=25). **= p < 0.01, Mann Whitney U test
Friedman analysis of variance was performed to examine if air conduction  thresholds 
improved over time. A significant improvement was shown from the neonatal ABR-
test to the test at 36 months of age, p < 0.05 in CP±L-group; p < 0.001 in group 
without CP±L. When  analysing the thresholds from 12 months to 36 months of 
age, there was a significant improvement in the group without CP±L (p < 0.001), 
but not in the cleft group.
A group-wise comparison was performed of the proportion of subjects designated 
as pass or fail result at the neonatal ABR test and at each of the 7 different test 
occasions. The Fisher exact 2-tailed test was used, and the analyses showed no 
significant between-group differences at any age. 
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6 DISCUSSION 
6.1 Hearing sensitivity
Study I
In this retrospective study on children with UCLP, the comparison of hearing 
 thresholds in the speech frequencies 500 - 4000 Hz demonstrated a significant 
improvement with age. The proportion of children with 4PTA > 20 dB HL in at 
least one ear declined from 4-7 years of age to > 7-10 years of age. The  comparison 
of the thresholds in the higher frequencies, 6000-8000 Hz, could not display an 
improvement in proportions of children with PTAHF > 20 dB HL in at least one ear. 
The improvement of hearing thresholds in the speech frequencies are in concord-
ance with the findings in several earlier studies on children with CP±L (Skuladottir 
et al., 2015). The declining frequency of OME-related hearing impairment in the 
speech frequencies is hypothesized to be due to the declining frequency of OME 
with age. In a study by Handzic-Cuk (Handzic-Cuk et al., 2001) the  decreasing 
frequency of type B tympanograms with age correlated with better hearing thresh-
olds with age. 
In the present study, the findings with no improvement at 6000-8000 Hz are com-
parable to a study by Flynn et al, in which the PTAHF at 7, 10, 13 and 16 years of 
age were compiled, and the analyses did not reveal any significant improvement 
with age (Flynn et al., 2013).
In the current study two children had the first VT-insertion before six months of 
age, 19 children before two years of age, 7 children before four years of age and 
one child after four years of age. Four children had no VT treatment. There was 
no significant correlation between number of VT insertions and the PTA4 and 
PTAHF for each ear at > 7-10 years of age (Pearson Correlation test).
The prevalence of persistent perforation of the eardrum (6.1%) and acquired 
cholesteatoma (6.1%) in the study, was in line with the range reported in the lit-
erature (Kuo et al., 2014). Spilsbury and colleagues (2013) examined a cohort of 
56,949 children who had undergone at least one VT treatment. Cholesteatoma was 
developed in 6.9% of the children with cleft palate by 18 years of age compared 
to 1.5% of children without cleft palate. In a retrospective cohort study on 2737 
children with various cleft palate the incidence of acquired cholesteatoma was 
2.2% between 5 and 18 years of age (Harris et al., 2013).   
Many studies have described a relationship between the number of VT treatments 
and higher hearing thresholds and higher incidence of complications, such as per-
foration of the eardrum and cholesteatoma (Ryding et al., 2005; Sheahan et al., 
2003). If these sequalae are caused by the chronic and protracted disease, or if 
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the VT treatments can increase the risk for these consequences is unclear because 
they are often concomitant. Children with more severe and protracted disease 
are treated more often with VT than those with shorter duration of the disease. 
Furthermore, both VT-insertion, Eustachian tube dysfunction and chronic otitis 
can cause myringosclerosis, retraction and perforation of the ear drum. 
Study II
A comparison of the hearing thresholds between the two groups of children, could 
not provide evidence for worse hearing thresholds in the group of children with 
cleft palate. The statistical analysis of the median ABR thresholds did not reveal 
any significant difference between the two groups which is analogous with a study 
by Sundman et al. (2016). The significantly better thresholds at 12 months in the 
group with CP±L is likely due to the early treatment with ventilation tubes in the 
cleft group at this age. The children without cleft palate had ventilation tubes 
inserted later, and at 24 and 36 months of age there was no significant group-wise 
difference regarding hearing thresholds. The hearing thresholds, from the neonatal 
ABR thresholds to 36 months of age showed a significant improvement over time 
in both groups. Since ABR thresholds are not directly analogous with behavioral 
thresholds an analysis was also performed from 12 to 36 months of age, with 
significant improvement only in the group without cleft. The comparison of the 
pass to fail ratio between the two groups did not show any significant group-wise 
difference at any test occasion. 
Early routine insertion of VT before the time of palatal repair has been widely 
discussed. In a controlled prospective study on 39 children with cleft palate and 
controls with OME but without cleft, all children had ventilation tubes before 
7 months of age (Valtonen et al., 2005). At follow-up six years later, the mean 
pure tone average and otological outcome were similar in the groups. On the other 
hand, protocol with selective tube placement has been recommended in children 
with hearing loss or symptomatic infection, instead of routine tube placement at 
the time of palatal repair, due to findings of no difference in incidence of persistent 
conductive hearing loss with a selective, compared to routine tube placement (Phua 
et al., 2009). In a retrospective study by Shaffer and colleagues on 318 children 
with cleft palate, the impact of hearing loss and timing of VT insertion on speech 
outcomes was analyzed. Hearing loss after multiple tube treatment were  associated 
with speech and language delays, but there was no evidence to support VT before 
palatoplasty (Shaffer et al., 2017).
Hearing aids can be an alternative for the management of OME-associated hearing 
loss in children with treatment resistant otorrhea after VT insertion or when general 
anesthesia for insertion of VT is not recommended. Comparisons between treat-
ments with VT and hearing aids in children with cleft palate has been presented in 
a study by Gani et al. The authors recommend a protocol which combines the short-
term benefit of VT insertion with the lower complication rate of HA (Gani 2012).
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In the longitudinal study, nine of the children with cleft palate had VT in place at 
12 months of age, but none of the children in the group without cleft palate had 
undergone VT insertion at this age. At 24 months of age four of the children with-
out and nine of the children with cleft palate had VT in at least one ear, and at 36 
months of age eight children without and six children with cleft palate had VT in at 
least one ear. The early treatment with ventilation tubes in CP±L group compared to 
the group without cleft palate did not result in any significant difference in median 
4 FA at 24 months, and the median 4FA at 36 months was normal in both groups. 
However, the two study groups were small, and a significant difference in 4FA at 24 
and 36 months of age might have been revealed with a larger number of participants.
6.2 Methodology discussion and Limitations
In study I the follow-up of the children with data about OME and recurrent acute 
OME was documented by the local ENT in some children, and due to different 
clinical routines, data about middle ear status was not always available at the time 
of the hearing assessment. Therefore, it was not possible to adequately examine 
how the severity and time with OME affected the hearing thresholds, indicating 
some uncertainty. Furthermore, the study is retrospective, and data may have been 
incomplete due to a missed appointment.
The aim in study II was to describe hearing thresholds in children with CP±L com-
pared with children with OME but without CP±L. In the longitudinal methodology 
in study II, the children in both groups were monitored closely from early infancy 
and followed up to 3 years of age. The aim was to collect more accurate data on 
hearing from newborn hearing screening until 3 years of age and to be able to 
make group-wise comparisons. By comparing two groups of children without any 
associated syndromes, anomalies or other physical impairment, the risk for devel-
opmental delays and non-compliance in the test situation decreased. Furthermore, 
the prevalence of sensorineural hearing loss is higher among children with associ-
ated syndromes, for example Sticklers syndrome and van der Woudes syndrome. 
In study II the children were very young, and the child´s compliance had impact 
on the result. The different tests´ abilities to detect small differences in hearing 
thresholds might have had an influence on the result. Missing data due to missed 
appointment decreased the number of participants, and small differences between 
the two groups might have been undetectable.
A comparison of mean and median values between two groups may be  misleading 
if the distribution consists of many outliers. This is often the case in a group of 
children with middle ear disease regarding the prevalence of complications as 
permanent hearing loss and abnormalities in the middle ear. Therefore,  clinical out-
comes of the children with complications should be studied separately to enhance 
the knowledge about how to treat children with cleft palate.
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7 CONCLUSION AND CLINICAL 
IMPLICATIONS
Assessments of hearing thresholds in children with cleft palate are important in 
order to evaluate the severity of potential OME related hearing loss. These two 
studies demonstrated improved thresholds in the speech frequencies at 500-4000 
Hz with age. In the higher frequencies, the group-wise comparison in study I did 
not reveal any significant improvement with age.
In the prospective longitudinal study, the better hearing thresholds at 12 months 
of age in the group with cleft palate, probably due to early VT insertion might 
have benefits for early speech and language development. This result should be 
followed up with further longitudinal studies. The high prevalence of OME and 
the risk for hearing impairment at early age during the period of early speech 
and language development, implies that children with cleft palate requires close 
follow-up with audiological and otological examinations to ensure that hearing 
impairment is managed appropriately. 
To improve the healthcare of children with cleft palate, an evidence-based con-
sensus concerning the treatment of otitis media and the following conductive 
hearing loss is needed.  
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8 FUTURE RESEARCH 
Study II is part of a prospective longitudinal project on the early development 
of speech, language, and hearing (TUTH – Tidig Utveckling av Tal och Hörsel) 
(Lohmander, 2013), in children with OME with or without cleft palate. In the 
next part babbling, consonant proficiency, and vocabulary will be analyzed. The 
results will add to an evidence-based consensus about the best way to treat children 
with cleft palate and OME. However, in order to fully understand the relationship 
between hearing thresholds and early speech and language development in children 
with CP±L prospective, randomized, multicenter, longitudinal studies are needed. 
Future research with standardized management protocols with close follow-up of 
middle-ear disease, hearing thresholds and speech- and language development 
will hopefully shed more light on this issue
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